EyeMed Technologies
Premium Lens for Intraocular Implantation
Company Overview
Snapshot
Founded in April 2018 by Nir Shimoni and Vadim Shmukler, EyeMed Technologies operates with 1–10 employees. The company has raised $5.8M across three funding rounds from MEDX Xelerator. In November 2023, EyeMed Technologies closed a Series A funding round.
Business overview
EyeMed Technologies is a Health Tech & Life Sciences company focused on developing advanced medical devices for ophthalmology. The company's core product is VaLens, an intraocular lens (IOL) designed to overcome effective lens position (ELP) prediction and IOL positioning errors. VaLens allows for repeatable, non-invasive optimization after lens implantation and wound healing, enabling cataract surgeons to precisely adjust the lens's position and power post-surgery. EyeMed Technologies operates within the Medical Devices and Medical Treatment & Therapeutics sectors, targeting the healthcare and medical products industries.
Strategic signal
In November 2023, EyeMed Technologies closed a Series A funding round. This financing indicates continued investor confidence in the company's innovative VaLens technology and its potential to address critical challenges in cataract surgery and post-operative care, signaling strong momentum for product development and market entry.
Company Intelligence Q&A
- When was EyeMed Technologies founded?
- EyeMed Technologies was founded in April 2018.
- Who are the founders of EyeMed Technologies?
- Nir Shimoni and Vadim Shmukler are the co-founders of EyeMed Technologies.
- What is EyeMed Technologies' primary product?
- EyeMed Technologies is developing VaLens, an intra-ocular lens (IOL) designed for post-operative adjustment in cataract surgery.
- What was a significant funding event for EyeMed Technologies?
- In November 2023, EyeMed Technologies closed a Series A funding round, raising over $5M. This round was led by MEDX Xelerator.
- Which investor participated in a funding round for EyeMed Technologies?
- MEDX Xelerator participated in a funding round for EyeMed Technologies in November 2023.